[
  {
    "id": "metformin",
    "name": "Metformin",
    "searchTerms": ["metformin", "glucophage"],
    "className": "Biguanide, oral hypoglycaemic",
    "tags": ["Diabetes", "eGFR-based"],
    "usualDose": "Typically 1–2 g/day in divided doses (max 2–3 g/day depending on prep).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "No dose change",
        "details": "Usual dosing with annual renal monitoring and checks before contrast/surgery."
      },
      {
        "min": 45,
        "max": 60,
        "label": "eGFR 45–59 mL/min/1.73 m²",
        "category": "Caution",
        "details": "Standard doses often fine; increase monitoring frequency and avoid starting in very high-risk patients."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30–44 mL/min/1.73 m²",
        "category": "Dose reduction",
        "details": "Reduce total daily dose (e.g. ~50%) and monitor 3-monthly. Stop during acute illness or dehydration."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30 mL/min/1.73 m²",
        "category": "Avoid",
        "details": "Avoid metformin due to lactic acidosis risk; use alternative glucose-lowering strategy."
      }
    ],
    "notes": [
      "Stop temporarily for sepsis, dehydration, hypoxia, contrast and major surgery."
    ]
  },
  {
    "id": "gliclazide",
    "name": "Gliclazide",
    "searchTerms": ["gliclazide"],
    "className": "Sulfonylurea",
    "tags": ["Diabetes", "Hypoglycaemia risk"],
    "usualDose": "40–320 mg/day in 1–2 doses (MR usually once daily).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard dosing",
        "details": "Use usual titration; monitor for hypoglycaemia."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Caution",
        "details": "Lower starting dose and cautious titration; increased risk of prolonged hypos."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Use with care",
        "details": "Prefer alternatives; if used, very low doses with close monitoring."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Generally avoid",
        "details": "Avoid because of significant hypoglycaemia risk."
      }
    ],
    "notes": [
      "Warn about driving and hypos, especially as renal function declines."
    ]
  },
  {
    "id": "insulin-basal",
    "name": "Basal insulin (e.g. insulin glargine)",
    "searchTerms": ["insulin", "glargine", "lantus", "abasaglar"],
    "className": "Basal insulin analogue",
    "tags": ["Diabetes"],
    "usualDose": "Once or twice daily, fully individualised by glucose profile.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "Adjust to glucose",
        "details": "No fixed renal table; insulin requirements usually fall as eGFR declines. Use glucose readings to titrate."
      }
    ],
    "notes": [
      "Hypoglycaemia risk rises in CKD; review total insulin dose regularly."
    ]
  },
  {
    "id": "empagliflozin",
    "name": "Empagliflozin",
    "searchTerms": ["empagliflozin", "jardiance"],
    "className": "SGLT2 inhibitor",
    "tags": ["Diabetes", "HF", "CKD"],
    "usualDose": "10–25 mg once daily depending on indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard use",
        "details": "Usual doses for T2DM/HF/CKD as per SPC."
      },
      {
        "min": 20,
        "max": 60,
        "label": "eGFR 20–59",
        "category": "Indication-dependent",
        "details": "For HF/CKD, can often continue or initiate down to eGFR ~20; glucose-lowering effect reduced."
      },
      {
        "min": null,
        "max": 20,
        "label": "eGFR < 20",
        "category": "Check SPC",
        "details": "Often avoid initiating; continuing therapy requires specialist/label-based decision."
      }
    ],
    "notes": [
      "Follow SPC and local HF/CKD guidance for exact eGFR cut-offs."
    ]
  },
  {
    "id": "dapagliflozin",
    "name": "Dapagliflozin",
    "searchTerms": ["dapagliflozin", "forxiga"],
    "className": "SGLT2 inhibitor",
    "tags": ["Diabetes", "HF", "CKD"],
    "usualDose": "10 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard use",
        "details": "Use per SPC for T2DM/HF/CKD."
      },
      {
        "min": 15,
        "max": 60,
        "label": "eGFR 15–59",
        "category": "Indication-dependent",
        "details": "For HF/CKD indications can often be used down to eGFR ~15; minimal glycaemic effect at lower eGFR."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Avoid / specialist",
        "details": "Usually avoid; refer to SPC and renal/cardiology advice."
      }
    ],
    "notes": [
      "Monitor for genital infections, volume depletion and DKA risk."
    ]
  },

  {
    "id": "ramipril",
    "name": "Ramipril",
    "searchTerms": ["ramipril"],
    "className": "ACE inhibitor",
    "tags": ["HF", "Hypertension"],
    "usualDose": "2.5–10 mg once daily depending on indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard titration",
        "details": "Titrate to target with creatinine/potassium checks."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Start low, go slow",
        "details": "Start at low dose and titrate cautiously; stop/tweak if creatinine rises >~30% or K⁺ increases."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Careful use",
        "details": "Very low doses with frequent monitoring; consider nephrology/cardiology advice."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Specialist decision",
        "details": "Use only on specialist advice."
      }
    ],
    "notes": [
      "Apply sick-day rules – hold during dehydration/AKI risk."
    ]
  },
  {
    "id": "lisinopril",
    "name": "Lisinopril",
    "searchTerms": ["lisinopril"],
    "className": "ACE inhibitor",
    "tags": ["Hypertension", "HF"],
    "usualDose": "5–40 mg once daily depending on indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Use usual titration with monitoring."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Lower start",
        "details": "Start at low dose and titrate slowly with U&E checks."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Specialist / cautious",
        "details": "Low-dose use only with close monitoring and often specialist input."
      }
    ],
    "notes": [
      "Monitoring strategy similar to ramipril."
    ]
  },
  {
    "id": "losartan",
    "name": "Losartan",
    "searchTerms": ["losartan", "cozaar"],
    "className": "ARB",
    "tags": ["Hypertension", "HF", "Diabetic nephropathy"],
    "usualDose": "25–100 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Usual doses with U&E monitoring."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Lower starting dose",
        "details": "Start at 25–50 mg and titrate slowly."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Specialist / cautious",
        "details": "Low doses only with frequent monitoring or specialist advice."
      }
    ],
    "notes": [
      "ARB monitoring and cautions similar to ACE inhibitors."
    ]
  },
  {
    "id": "candesartan",
    "name": "Candesartan",
    "searchTerms": ["candesartan"],
    "className": "ARB",
    "tags": ["HF", "Hypertension"],
    "usualDose": "4–32 mg once daily, indication-dependent.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Use usual titration with renal and potassium checks."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Cautious titration",
        "details": "Use lower starting doses and titrate carefully."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Specialist",
        "details": "Low-dose use only with frequent U&E monitoring / specialist advice."
      }
    ],
    "notes": [
      "Commonly used in HF; follow local HF titration protocol if available."
    ]
  },
  {
    "id": "bisoprolol",
    "name": "Bisoprolol",
    "searchTerms": ["bisoprolol"],
    "className": "Beta-1 selective beta-blocker",
    "tags": ["HF", "Hypertension"],
    "usualDose": "Heart failure: 1.25–10 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard titration",
        "details": "Titrate per HF/HTN protocol."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "No formal change",
        "details": "Usually no structured dose change, but titrate slowly in frail/CKD."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Caution",
        "details": "Monitor closely for bradycardia/hypotension; specialist advice in advanced CKD."
      }
    ],
    "notes": [
      "Partly renally cleared; accumulation may contribute to bradycardia in CKD."
    ]
  },
  {
    "id": "furosemide",
    "name": "Furosemide",
    "searchTerms": ["furosemide", "frusemide"],
    "className": "Loop diuretic",
    "tags": ["HF", "Oedema"],
    "usualDose": "20–80 mg once or twice daily; higher doses in CKD.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Use lowest effective dose with monitoring of U&E and volume status."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Higher doses often",
        "details": "May need higher doses; monitor for AKI and electrolyte disturbance."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Specialist titration",
        "details": "High doses and/or IV often required; usually titrated by HF/renal teams."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 / dialysis",
        "category": "Individualised",
        "details": "Use only with specialist guidance."
      }
    ],
    "notes": [
      "Avoid over-diuresis; assess weight, JVP, BP and renal function."
    ]
  },
  {
    "id": "spironolactone",
    "name": "Spironolactone",
    "searchTerms": ["spironolactone"],
    "className": "Aldosterone antagonist",
    "tags": ["HF", "Hyperkalaemia risk"],
    "usualDose": "HF: typically 25–50 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard low dose",
        "details": "Use usual HF doses with U&E monitoring."
      },
      {
        "min": 45,
        "max": 60,
        "label": "eGFR 45–59",
        "category": "Caution",
        "details": "Consider 25 mg on alternate days and closer K⁺ monitoring."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30–44",
        "category": "High hyperkalaemia risk",
        "details": "Often avoid or use very low doses with frequent U&E."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Generally avoid",
        "details": "Usually avoided outside specialist settings."
      }
    ],
    "notes": [
      "Stop or reduce if K⁺ rises or creatinine increases significantly."
    ]
  },
  {
    "id": "atorvastatin",
    "name": "Atorvastatin",
    "searchTerms": ["atorvastatin"],
    "className": "Statin",
    "tags": ["Lipids"],
    "usualDose": "10–80 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal renal adjustment",
        "details": "Generally no structured dose change; use usual CKD dose recommendations (often 20 mg+ for secondary prevention)."
      }
    ],
    "notes": [
      "Monitor for myopathy; adjust if CK or symptoms problematic."
    ]
  },
  {
    "id": "simvastatin",
    "name": "Simvastatin",
    "searchTerms": ["simvastatin"],
    "className": "Statin",
    "tags": ["Lipids"],
    "usualDose": "10–40 mg once daily in the evening.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Usual doses with routine monitoring."
      },
      {
        "min": null,
        "max": 60,
        "label": "eGFR < 60",
        "category": "No major change",
        "details": "Often no formal adjustment, but some guidance suggests lower starting doses in advanced CKD."
      }
    ],
    "notes": [
      "Be aware of drug interactions and myopathy risk."
    ]
  },

  {
    "id": "apixaban",
    "name": "Apixaban",
    "searchTerms": ["apixaban", "eliquis", "doac"],
    "className": "Direct factor Xa inhibitor",
    "tags": ["DOAC", "AF", "VTE"],
    "usualDose": "AF: 5 mg twice daily, or 2.5 mg twice daily if dose-reduction criteria.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "CrCl ≥ 50",
        "category": "Standard dosing",
        "details": "Use labelled dose for indication."
      },
      {
        "min": 30,
        "max": 50,
        "label": "CrCl 30–49",
        "category": "Caution / possible reduction",
        "details": "Often reduced dose in AF if criteria met; check SPC/SPS/local DOAC protocol."
      },
      {
        "min": 15,
        "max": 30,
        "label": "CrCl 15–29",
        "category": "Reduced dose / specialist",
        "details": "AF: usually 2.5 mg bd with caution; VTE often specialist-only decision."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 / dialysis",
        "category": "Avoid",
        "details": "Most UK guidance: avoid DOACs and consider warfarin or no anticoagulation."
      }
    ],
    "notes": [
      "Always use Cockcroft–Gault CrCl, not eGFR, for DOAC dosing."
    ]
  },
  {
    "id": "rivaroxaban",
    "name": "Rivaroxaban",
    "searchTerms": ["rivaroxaban", "xarelto", "doac"],
    "className": "Direct factor Xa inhibitor",
    "tags": ["DOAC", "AF", "VTE"],
    "usualDose": "AF: 20 mg od with food; 15 mg od if CrCl 15–49.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "CrCl ≥ 50",
        "category": "Standard",
        "details": "Use labelled dose for AF/VTE."
      },
      {
        "min": 15,
        "max": 50,
        "label": "CrCl 15–49",
        "category": "Reduced dose",
        "details": "AF: 15 mg od; check SPC and SPS for other indications."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15",
        "category": "Avoid",
        "details": "Avoid rivaroxaban; consider alternatives."
      }
    ],
    "notes": [
      "Assess bleeding risk and renal function regularly."
    ]
  },
  {
    "id": "edoxaban",
    "name": "Edoxaban",
    "searchTerms": ["edoxaban", "lixiana", "doac"],
    "className": "Direct factor Xa inhibitor",
    "tags": ["DOAC", "AF", "VTE"],
    "usualDose": "AF: 60 mg od; 30 mg od if CrCl 15–50, low weight or certain interactions.",
    "renalBands": [
      {
        "min": 50,
        "max": 95,
        "label": "CrCl 50–95",
        "category": "Standard",
        "details": "Use 60 mg od if other reduction criteria not met."
      },
      {
        "min": 15,
        "max": 50,
        "label": "CrCl 15–49",
        "category": "Reduced dose",
        "details": "Usually 30 mg od; check SPC."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15",
        "category": "Avoid",
        "details": "Avoid edoxaban; use alternative."
      }
    ],
    "notes": [
      "Avoid if CrCl > 95 mL/min in AF due to reduced efficacy."
    ]
  },
  {
    "id": "warfarin",
    "name": "Warfarin",
    "searchTerms": ["warfarin"],
    "className": "Vitamin K antagonist",
    "tags": ["Anticoagulant"],
    "usualDose": "Highly individualised to INR.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "INR-guided",
        "details": "No fixed renal adjustment; dose to INR within target range."
      }
    ],
    "notes": [
      "Bleeding risk higher in CKD; monitor INR and interactions closely."
    ]
  },

  {
    "id": "gabapentin",
    "name": "Gabapentin",
    "searchTerms": ["gabapentin", "neurontin"],
    "className": "Antiepileptic / neuropathic pain",
    "tags": ["Neuropathic pain", "Renally cleared"],
    "usualDose": "900–3600 mg/day in 3 doses in normal renal function.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "CrCl ≥ 60",
        "category": "Standard",
        "details": "Usual titration up to local max."
      },
      {
        "min": 30,
        "max": 60,
        "label": "CrCl 30–59",
        "category": "Moderate reduction",
        "details": "Reduce total daily dose and/or frequency (e.g. ~600–1800 mg/day)."
      },
      {
        "min": 15,
        "max": 30,
        "label": "CrCl 15–29",
        "category": "Significant reduction",
        "details": "Low doses (e.g. 300–600 mg/day) with slow titration."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 / dialysis",
        "category": "Specialist dosing",
        "details": "Very low or post-dialysis dosing only."
      }
    ],
    "notes": [
      "Accumulation causes sedation/ataxia; use CrCl rather than eGFR if possible."
    ]
  },
  {
    "id": "pregabalin",
    "name": "Pregabalin",
    "searchTerms": ["pregabalin", "lyrica"],
    "className": "Antiepileptic / neuropathic pain / GAD",
    "tags": ["Neuropathic pain", "Renally cleared"],
    "usualDose": "150–600 mg/day in 2–3 divided doses.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "CrCl ≥ 60",
        "category": "Standard",
        "details": "Use usual titration schedule."
      },
      {
        "min": 30,
        "max": 60,
        "label": "CrCl 30–59",
        "category": "Dose reduction",
        "details": "Lower maximum daily dose (e.g. up to ~300 mg/day)."
      },
      {
        "min": 15,
        "max": 30,
        "label": "CrCl 15–29",
        "category": "Marked reduction",
        "details": "Substantially reduced doses (e.g. up to ~150 mg/day)."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 / dialysis",
        "category": "Specialist",
        "details": "Very low/post-dialysis dosing only."
      }
    ],
    "notes": [
      "Accumulation increases sedation, dizziness and oedema; taper slowly when stopping."
    ]
  },
  {
    "id": "sertraline",
    "name": "Sertraline",
    "searchTerms": ["sertraline"],
    "className": "SSRI antidepressant",
    "tags": ["Depression", "Anxiety"],
    "usualDose": "50–200 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal adjustment",
        "details": "Usually no structured dose change; start low and titrate by response."
      }
    ],
    "notes": [
      "Monitor for hyponatraemia, especially in older patients and CKD."
    ]
  },
  {
    "id": "mirtazapine",
    "name": "Mirtazapine",
    "searchTerms": ["mirtazapine"],
    "className": "NaSSA antidepressant",
    "tags": ["Depression"],
    "usualDose": "15–45 mg at night.",
    "renalBands": [
      {
        "min": 40,
        "max": null,
        "label": "eGFR ≥ 40",
        "category": "Standard",
        "details": "Usual dose range with clinical monitoring."
      },
      {
        "min": null,
        "max": 40,
        "label": "eGFR < 40",
        "category": "Caution",
        "details": "Consider lower doses and slower titration; monitor for sedation."
      }
    ],
    "notes": [
      "Can cause weight gain and sedation; useful for insomnia/poor appetite."
    ]
  },
  {
    "id": "venlafaxine",
    "name": "Venlafaxine",
    "searchTerms": ["venlafaxine"],
    "className": "SNRI antidepressant",
    "tags": ["Depression", "Anxiety"],
    "usualDose": "75–225 mg/day (immediate or modified-release).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Usual dose range as per BNF."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Dose reduction",
        "details": "Reduce total daily dose (e.g. by ~25–50%) and titrate slowly."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Further reduction",
        "details": "Use low doses only and monitor closely; consider alternatives in severe CKD."
      }
    ],
    "notes": [
      "Monitor BP and withdrawal symptoms on discontinuation."
    ]
  },
  {
    "id": "amitriptyline",
    "name": "Amitriptyline",
    "searchTerms": ["amitriptyline"],
    "className": "Tricyclic antidepressant",
    "tags": ["Depression", "Neuropathic pain"],
    "usualDose": "10–75 mg at night for pain (higher for depression under specialist care).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "Clinical titration",
        "details": "No formal renal table; start low and titrate by tolerability, particularly in older adults/CKD."
      }
    ],
    "notes": [
      "Anticholinergic and cardiac side-effects limit use in frailer CKD patients."
    ]
  },

  {
    "id": "amoxicillin",
    "name": "Amoxicillin",
    "searchTerms": ["amoxicillin"],
    "className": "Aminopenicillin antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "500 mg tds (higher for severe infection).",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard",
        "details": "Usual dose and interval."
      },
      {
        "min": 10,
        "max": 30,
        "label": "eGFR 10–29",
        "category": "Extended interval",
        "details": "Reduce frequency (e.g. bd) according to severity and local guidance."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10 / dialysis",
        "category": "Further reduction",
        "details": "Lower dose or longer interval; seek renal/microbiology advice in severe infection."
      }
    ],
    "notes": [
      "Follow local antimicrobial guidance for indication and exact dosing."
    ]
  },
  {
    "id": "co-amoxiclav",
    "name": "Co-amoxiclav",
    "searchTerms": ["co-amoxiclav", "amoxicillin clavulanic"],
    "className": "Amoxicillin + clavulanic acid",
    "tags": ["Antibiotic"],
    "usualDose": "500/125 mg tds or 875/125 mg bd depending on prep.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard",
        "details": "Usual dosing per indication."
      },
      {
        "min": 10,
        "max": 30,
        "label": "eGFR 10–29",
        "category": "Extended interval",
        "details": "Reduce frequency (e.g. bd) as per BNF/local guidance."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10 / dialysis",
        "category": "Further reduction",
        "details": "Consider alternative or further dose/interval reduction with specialist advice."
      }
    ],
    "notes": [
      "Monitor LFTs if prolonged course; be aware of cholestatic hepatitis risk."
    ]
  },
  {
    "id": "nitrofurantoin",
    "name": "Nitrofurantoin",
    "searchTerms": ["nitrofurantoin", "macrobid"],
    "className": "Urinary antibacterial",
    "tags": ["UTI"],
    "usualDose": "100 mg MR bd or 50 mg qds for 3–7 days.",
    "renalBands": [
      {
        "min": 45,
        "max": null,
        "label": "eGFR ≥ 45",
        "category": "Standard short course",
        "details": "Use for lower UTI only if no upper tract features."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30–44",
        "category": "Short course only",
        "details": "Some guidance allows short-course use if benefits outweigh risks; avoid prophylaxis."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Avoid",
        "details": "Avoid due to poor urinary levels and higher toxicity risk."
      }
    ],
    "notes": [
      "Avoid in suspected pyelonephritis or sepsis."
    ]
  },
  {
    "id": "trimethoprim",
    "name": "Trimethoprim",
    "searchTerms": ["trimethoprim"],
    "className": "Dihydrofolate reductase inhibitor",
    "tags": ["UTI", "Hyperkalaemia risk"],
    "usualDose": "200 mg bd for 3–7 days (acute UTI).",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard",
        "details": "Usual short course dosing."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Dose reduction",
        "details": "Reduce total dose or extend interval (e.g. 200 mg od)."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Avoid / specialist",
        "details": "Avoid if possible due to hyperkalaemia and creatinine rise."
      }
    ],
    "notes": [
      "Check K⁺ and creatinine if using in patients on ACEI/ARB/spironolactone."
    ]
  },
  {
    "id": "cefalexin",
    "name": "Cefalexin",
    "searchTerms": ["cefalexin", "cephalexin"],
    "className": "1st-generation cephalosporin",
    "tags": ["Antibiotic"],
    "usualDose": "500 mg bd–qds depending on indication.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR ≥ 50",
        "category": "Standard",
        "details": "Usual dose and frequency."
      },
      {
        "min": 10,
        "max": 50,
        "label": "eGFR 10–49",
        "category": "Extended interval",
        "details": "Reduce frequency (e.g. bd) as per BNF/local guidance."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Further reduction",
        "details": "Low dose or longer interval; seek renal/micro advice in serious infection."
      }
    ],
    "notes": [
      "Watch for neurotoxicity at very low eGFR and high doses."
    ]
  },

  {
    "id": "digoxin",
    "name": "Digoxin",
    "searchTerms": ["digoxin"],
    "className": "Cardiac glycoside",
    "tags": ["HF", "Rate control", "Narrow therapeutic index"],
    "usualDose": "62.5–250 micrograms od according to age, renal function and indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard low-ish dosing",
        "details": "Use lower doses in older adults; monitor levels if concern."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Dose reduction",
        "details": "Often 62.5–125 micrograms od or on alternate days; check levels if possible."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Marked reduction",
        "details": "Very low doses (e.g. 62.5 micrograms od/alt days); monitor for toxicity."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Specialist dosing",
        "details": "Dose only with level monitoring and specialist supervision."
      }
    ],
    "notes": [
      "Toxicity risk rises in CKD, hypokalaemia and hypomagnesaemia; review interacting drugs."
    ]
  }
]
